BioStrand Omics Analysis Blog:
AI (2)

A Hybrid Approach to NLP in Drug Discovery

Dr Ingrid Brands, General Manager | June 8, 2022

Artificial Intelligence-powered technologies like NLP are becoming critical to the pharmaceutical...

AI in early phase drug development

Dr Ingrid Brands, General Manager | June 1, 2022

AI technologies are currently the most disruptive trend in the pharmaceutical industry. Over the...

Efficient data integration is the key to effective AI/ML

Dr Ingrid Brands, General Manager | May 18, 2022

AI/ML technologies can be notoriously data-hungry with the broader concern being that certain...

Knowledge Graphs & The Power Of Context

Dr Ingrid Brands, General Manager | April 20, 2022

Data overload is becoming a real challenge for businesses of all stripes even as a majority...

AI, ML, DL, and NLP: An Overview

Dr Ingrid Brands, General Manager | April 13, 2022

Today artificial intelligence (AI), machine learning (ML), deep learning (DL) and natural language...

Subscribe to our blog

AI in drug development - towards fully autonomous drug discovery

Dr Ingrid Brands, General Manager | March 30, 2022

In our previous blog, we noted how the increasing utilization of AI across different phases of the...

AI in drug development - from hype to reality

Dr Ingrid Brands, General Manager | March 16, 2022

Back in 1981, a Discovery magazine article called Designing Drugs With Computers detailed a...

The importance of NLP in biomedical research

Dr Ingrid Brands, General Manager | March 9, 2022

There will be more than twice as much digital data created over the next five years as has been...